In continuation of our effort to optimize the pharmacological profile of [1, 2-diamino-1, 2-bis (4-fluorophenyl) ethane] dichloridoplatinum (II) complexes, we synthesized [1, 2-diamino-1- (4-fluorophenyl) alkanol] dichloridoplatinum (II) analogs. The aim of this study was to